Background: Public health surveillance systems should be evaluated periodically to ensure the problems of public health importance are being monitored efficiently and effectively. Despite the widespread measles outbreak in Ginnir district of Ethiopia in 2019, an evaluation of measles surveillance systems has not been conducted. Therefore, we evaluated the performance of measles surveillance systems and key attributes in Ginnir district, Southeast Ethiopia. Methods: We conducted a concurrent embedded mixed quantitative/qualitative study in August 2019 among 15 health facilities/study units in Ginnir district. The qualitative study involved a purposively selected 15 key-informants. Data were collected using updated guidelines for evaluating surveillance systems based on CDC's Framework. Results: Records of 15 study units were reviewed and 15 key informants participated. The structure of surveillance data flow was from the community to the respective upper level. Emergency preparedness and a response plan was available only at the district level. Weekly report completeness and timeliness were 95% and 87% respectively. We found weak supportive supervision and feedback, and no regular analysis and interpretations of surveillance data. The participation of surveillance stakeholders in implementation of the system was good. The surveillance system was found to be useful, easy to implement, representative, and can accommodate and adapt to changing operating conditions. Report documentation and quality of data was poor at lower level health facilities. The stability of the system has been challenged by a shortage of budget, logistics, staff turnover and lack of update trainings. Conclusion: The surveillance system was acceptable, useful, simple, flexible, and representative. Quality of data, timeliness, and the stability of the system were attributes that require improvement. The overall performance of measles surveillance systems in prevention and control of measles was weak. Hence, regular analysis of data, preparation, and dissemination of epidemiological bulletin, capacity building, and regular supervision and feedback are recommended to enhance performance of the system.
IntroductionIn Ethiopia, the prevalence of anemia in pregnant women differs geographically and ranged from 15.8–56.8%. The objective of this study is to identify the determinants of anemia among pregnant women attending antenatal care in health facilities of Bale-Robe Town, Southeast Ethiopia.MethodsA facility-based case-control study was conducted in Bale-Robe hospital and Baha-biftu health center in Bale-Robe, Southeast Ethiopia. A total of 282 pregnant women participated in the study (141 cases and 141 controls). Cases were pregnant women with altitude-adjusted hemoglobin value < 11.0 g/dl at the first and third trimesters, and < 10.5 g/dl at the second trimester. Controls were pregnant women with hemoglobin value ≥ 11.0 g/dl at first and third trimesters and ≥ 10.5 g/dl at the second trimester. A structured and pretested questionnaire was used to collect data. A multivariable logistic regression analysis was applied to assess the determinants of anemia. Determinants were categorized as sociodemographic and economic, obstetric and medical, and dietary intake and behavioral.ResultsHousewife occupation (AOR=2.1, 95% CI=1.12-3.92), prolonged menstrual bleeding (AOR=2.33, 95% CI=1.38-3.92) and undernutrition (AOR=4.03, 95% CI=1.38-11.83) were factors significantly associated with anemia in pregnant women.ConclusionHousewife occupation, prolonged menstrual bleeding, and malnutrition were the determinants of anemia in pregnant women. Hence, anemia prevention and control strategy in pregnant women should include adequate dietary intake, and strengthening nutritional counseling for pregnant women during antenatal care is also required by the health care provider.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.